Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: Their Role in Clinical Chemistry

In view of current (AChE inhibitors) and future (e.g. anti-Aβ aggregators), development and evaluation of cerebrospinal fluid (CSF) biomarkers for Alzheimer’s disease (AD) has become a rapidly growing research field. Diagnostic biomarkers for AD would be especially valuable as aids in the diagnosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Blennow, Kaj, Galasko, Douglas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Communications and Publications Division (CPD) of the IFCC 2000
Materias:
Data Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341233/
https://www.ncbi.nlm.nih.gov/pubmed/30675139

Ejemplares similares

Ejemplares similares